Novozymes is unlocking growth by delivering strong Q3 results and increasing full-year guidance Novozymes delivered 7% organic sales growth in the third quarter and 6% organic sales growth in the first nine months of 2021. Due to stronger performance the company has upgraded its full-year...

Novozymes is unlocking growth with the ambition of doubling company revenue by 2030 With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales growth target of 5+% CAGR for the 5-year period until 2025, coupled with...

Novozymes is combining cutting-edge science and business expertise to help feed the world sustainably To feed a growing population, Novozymes is inviting all interested parties to help co-create and innovate the future of sustainable protein. By combining science with business expertise Novozymes...

Attis Announces Collaboration with Novozymes to Provide Bio-technology for Ethanol Production at its Biorefineries MILTON, GA, Jan. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Attis Industries Inc.(NASDAQ: ATIS) (the "Company" or "Attis"), a diversified innovation and technology holding company today...

Synthetic Biology Market Growing With Rise In Medical Demand - IndustryARC Hyderabad, India, March 17, 2017 (GLOBE NEWSWIRE) -- The report “Synthetic Biology Market: By Tool (XNAS, Chassis Organisms) By Technology (Bioinformatics, DNA sequencing, integrated systems) By...